Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in FOLD / Amicus Therapeutics, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 4,560,810 shares of Amicus Therapeutics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -100.00 0
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 4,560,810 -3,161,508 -40.94 35,939 -18.78 0.0419
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 7,722,318 907,236 13.31 44,249 -20.43 0.0543
2025-08-14 2025-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 6,815,082 187,060 2.82 55,611 -10.93 0.0690
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 6,815,082 187,060 55,611 0.0454
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 6,628,022 -341,857 -4.90 62,436 -16.12 0.0758
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 6,969,879 -151,343 -2.13 74,438 5.37 0.0804
2024-08-09 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 7,121,222 50,489 0.71 70,643 -15.19 0.0810
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 7,070,733 -144,277 -2.00 83,293 -18.64 0.0945
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 7,215,010 2,358 0.03 102,381 16.73 0.1183
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 7,212,652 290,671 4.20 87,706 0.88 0.1102
2023-10-27 2023-06-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 6,921,981 -249,054 -3.47 86,940 9.32 0.0994
2023-10-12 2023-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 6,921,981 -249,054 86,940 0.0874
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,921,981 -249,054 86,940 0.0882
2023-06-01 2023-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 7,171,035 212,988 3.06 79,527 -6.39 0.0945
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 7,171,035 212,988 79,527 0.0730
2023-02-21 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 6,958,047 80,286 1.17 84,958 18.29 0.1003
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 6,877,761 110,515 1.63 71,821 -1.18 0.0881
2022-08-17 2022-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 6,767,246 224,367 3.43 72,680 17.30 0.0816
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,767,246 224,367 72,680 0.0260
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 6,542,879 248,193 3.94 61,961 -14.78 0.0471
2022-02-11 2021-12-31 13F Amicus Therapeutics COM 03152W109 6,294,686 -71,898 -1.13 72,704 19.58 0.0606
2021-11-12 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 6,366,584 77,743 1.24 60,801 0.29 0.0518
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 6,288,841 594,646 10.44 60,624 7.76 0.0498
2021-05-14 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 5,694,195 2,407,160 73.23 56,258 -25.88 0.0795
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,287,035 2,543,281 341.95 75,898 622.70 0.1108
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 743,754 618,632 494.42 10,502 456.54 0.0178
2020-08-11 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 125,122 -23,448 -15.78 1,887 37.44 0.0032
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 148,570 8,068 5.74 1,373 0.37 0.0028
2020-03-18 2019-12-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 140,502 140,502 1,368 0.0020
2020-02-28 2019-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 140,502 0 1,368 0.0020
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 140,502 1,368 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.